Evaluation and treatment of childhood obesity

Am Fam Physician. 1999 Feb 15;59(4):861-8, 871-3.

Abstract

The prevalence of childhood obesity in the United States has risen dramatically in the past several decades. Although 25 to 30 percent of children are affected, this condition is underdiagnosed and undertreated. Hormonal and genetic factors are rarely the cause of childhood obesity; unnecessary diagnostic evaluations can be avoided with a careful history and physical examination. Because obese children may suffer life-long physical and emotional consequences, it is imperative to discuss prevention with parents during well-child examinations. All obese children should be screened for cardiac risk factors, as well as for possible orthopedic, dermatologic and psychiatric sequelae. Treatment should be initiated when the trend in increasing weight obviously surpasses the trend in increasing height. Treatment plans should include reasonable weight-loss goals, dietary and physical activity management, behavior modification and family involvement, which may include weight loss in the parents. Anorexiant medications are not approved by the U.S. Food and Drug Administration for use in pediatric populations.

Publication types

  • Review

MeSH terms

  • Child
  • Humans
  • Obesity* / diagnosis
  • Obesity* / epidemiology
  • Obesity* / etiology
  • Obesity* / therapy
  • Patient Education as Topic
  • Prevalence
  • Severity of Illness Index
  • Teaching Materials
  • United States / epidemiology